GGrantIndex
← Leaderboards

Daniel J Morgan

Baltimore Va Medical Center

$4,664,612
Attributed
$4,664,612
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.7M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

AHRQ$2,347,112 · 2
NIH$2,317,500 · 1
VA$0 · 2

By mechanism

DP2$2,317,500 · 1
R01$1,718,796 · 1
K08$628,316 · 1
I01$0 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Caring

Research focus

CaringPhysiciansCenters For Disease Control And Prevention (U.S.)InterviewMarylandProtocols DocumentationSamplingDesignVeteransAdverse OutcomeAcutePatient CareLong-Term CareSafetyAdverse EventInfection PreventionInfectionHealthcare SystemsBasePsychologyReportingInnovationLifeDiagnosis

Grant awards (20)

Diagnostic Stewardship as a 'nudge' to reduce inappropriate antibiotic use for urinary tract infections$0
I01 · FY2025 · VA · contact PI
Diagnostic Stewardship as a 'nudge' to reduce inappropriate antibiotic use for urinary tract infections$0
I01 · FY2024 · VA · contact PI
Diagnostic Stewardship as a 'nudge' to reduce inappropriate antibiotic use for urinary tract infections$0
I01 · FY2023 · VA · contact PI
Diagnostic Stewardship as a 'nudge' to reduce inappropriate antibiotic use for urinary tract infections$0
I01 · FY2022 · VA · contact PI
Understanding and preventing Clostridium difficile transmission from asymptomatically colonized patients$415,791
R01 · FY2020 · HS · contact PI
Diagnostic Stewardship as a 'nudge' to reduce inappropriate antibiotic use for urinary tract infections$0
I01 · FY2020 · VA · contact PI
Understanding and preventing Clostridium difficile transmission from asymptomatically colonized patients$459,827
R01 · FY2019 · HS · contact PI
Comparative safety and effectiveness of isolation in VHA community living centers$0
I01 · FY2019 · VA · contact PI
Understanding and preventing Clostridium difficile transmission from asymptomatically colonized patients$419,226
R01 · FY2018 · HS · contact PI
Comparative safety and effectiveness of isolation in VHA community living centers$0
I01 · FY2018 · VA · contact PI
Comparative safety and effectiveness of isolation in VHA community living centers$0
I01 · FY2018 · VA · contact PI
Comparative safety and effectiveness of isolation in VHA community living centers$0
I01 · FY2018 · VA · contact PI
Incorporating Bayesian reasoning into physician testing and treatment decisions$2,317,500
DP2 · FY2017 · LM · contact PI
Understanding and preventing Clostridium difficile transmission from asymptomatically colonized patients$423,952
R01 · FY2017 · HS · contact PI
Comparative safety and effectiveness of isolation in VHA community living centers$0
I01 · FY2015 · VA · contact PI
Improving Patient Safety and Disease Management While on Contact Isolation$104,981
K08 · FY2013 · HS · contact PI
Improving Patient Safety and Disease Management While on Contact Isolation$130,544
K08 · FY2012 · HS · contact PI
Improving Patient Safety and Disease Management While on Contact Isolation$130,544
K08 · FY2011 · HS · contact PI
Improving Patient Safety and Disease Management While on Contact Isolation$127,196
K08 · FY2010 · HS · contact PI
Improving Patient Safety and Disease Management While on Contact Isolation$135,051
K08 · FY2009 · HS · contact PI